HAM
EDIT icon

HHR Asset Management’s Editas Medicine EDIT Stock Holding History

HHR Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,550
Closed -$3.54M – 38
2020
Q4 		$3.54M Sell
50,550
-17,510
-26% -$719K 0.3% 33
2020
Q3 		$1.91M Sell
68,060
-3,880
-5% -$126K 0.19% 30
2020
Q2 		$2.13M Sell
71,940
-11,910
-14% -$311K 0.21% 32
2020
Q1 		$1.66M Hold
83,850
– – 0.19% 35
2019
Q4 		$2.48M Sell
83,850
-8,380
-9% -$209K 0.24% 29
2019
Q3 		$2.1M Hold
92,230
– – 0.21% 27
2019
Q2 		$2.28M Buy
+92,230
New +$2.2M 0.17% 41

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HHR Asset Management's EDIT Position: Q1 2021 in Review

HHR Asset Management sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 50,550 shares — an estimated $3.54M sold.

HHR Asset Management first reported a position in EDIT in Q2 2019 and held it in 7 quarters. The position peaked at $3.54M in Q4 2020. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

  • HHR Asset Management reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
  • HHR Asset Management sold 50,550 Editas Medicine shares in Q1 2021, an estimated $3.54M.
  • HHR Asset Management first reported a position in Editas Medicine in Q2 2019 and held it in 7 quarters.
  • HHR Asset Management's Editas Medicine position peaked at $3.54M in Q4 2020.
  • 312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on HHR Asset Management's 13F filing for Q1 2021, filed 17 May 2021.